Stefan Berlin

Stefan Berlin is an experienced professional in regulatory affairs and project management within the pharmaceutical and biotechnology industries. Currently serving as the Head of Regulatory Affairs Biostimulators at Galderma since January 2019, Stefan has previously held roles such as Manager for Operations Project Management and Senior Project Manager, focusing on industrialization initiatives for the Galderma Aesthetics business. Prior experience includes serving as Director at Sobi, where the focus was on manufacturing and supply chain operations for rare disease treatments. At AstraZeneca, Stefan held various positions including Program Manager, Study Operations Specialist, Supply Chain Study Manager, and Senior Scientist, contributing to clinical development and the manufacturing of active pharmaceutical ingredients. Stefan holds a Doctor of Philosophy (PhD) in Organic Chemistry and a Master of Philosophy (fil.mag.) in Organic Chemistry, both from Uppsala University.